Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Arch. endocrinol. metab. (Online) ; 59(3): 215-219, 06/2015. tab, graf
Article Dans Anglais | LILACS | ID: lil-751319

Résumé

Objective The association between type 1 diabetes mellitus (T1D) and dyslipidemia (DLP) increases the risk of cardiovascular disease (CVD). The aim of this study was to evaluate the presence of dyslipidemia in young T1D patients.Materials and methods The study design was cross-sectional and descriptive. We reviewed medical records of T1D patients followed at an endocrinology service, from 1998-2012. Data collected: gender, actual age and age at diagnosis, duration of T1D since diagnosis, body mass index (BMI), pubertal stage, glycemic control (GC) determined by glycated hemoglobin (HbA1c), total cholesterol (TC), HDL, LDL, triglycerides (TG). To analyze lipid profile and metabolic control, we used the Brazilian Society of Diabetes Guidelines.Results Were included 239 T1D patients, 136 (56.9%) females; mean ± SD: actual age 15.7 ± 5.0 years and at T1D diagnosis 7.3 ± 3.9; T1D duration 10.6 ± 6.4 years, 86.6% puberty, 15.1% overweight. The prevalence of DLP was 72.5%, 63.3% females, 86.6% puberty, mean ± SD: actual age 15.4 ± 4.8 years and at T1D diagnosis 7.2 ± 4.1 years, duration of T1D 10.7 ± 6.1 years. We found high-CT in 56.7%, low-HDL = 21.7%, high LDL = 44.0%, high-TG = 11.8%. Between females with DLP, 83.5% was in puberty. We find correlation between the presence of DLP, a poor GC and BMC.Conclusion We found a high prevalence of DLP in young patients with T1D, particularly in puberty females. Programs targeting the prevention of dyslipidemia should be adopted, especially for this group, in order to prevent/delay chronic complications and cardiovascular disease. Arch Endocrinol Metab. 2015;59(3):215-9.


Sujets)
Animaux , Femelle , Cardiomyopathies/traitement médicamenteux , Hypertension rénovasculaire/thérapie , Mitochondries du myocarde/métabolisme , Peptides/pharmacologie , Angioplastie , Apoptose , Cardiomyopathies/étiologie , Cardiomyopathies/anatomopathologie , Collagène/métabolisme , Fibrose , Tests de la fonction cardiaque , Hypertension rénovasculaire/complications , Hypertension rénovasculaire/métabolisme , Tests de la fonction rénale , Microvaisseaux/ultrastructure , Stress oxydatif , Oxygène/métabolisme , Peptides/métabolisme , Suidae
SÉLECTION CITATIONS
Détails de la recherche